A New Paradigm of the Origins of Circulating DNA in Patients with Cancer
- PMID: 37794839
- DOI: 10.1158/2159-8290.CD-23-0824
A New Paradigm of the Origins of Circulating DNA in Patients with Cancer
Abstract
By shedding light on the cellular origins of circulating DNA (cirDNA), this research provides important insights into the mechanisms of cirDNA production in cancer. Contrary to expectations, the increased cirDNA in patients with cancer was not derived predominantly from neoplastic cells or surrounding nonneoplastic epithelial cells; rather, the excess cirDNA originated primarily from leukocytes, implying a systemic impact of cancer on cell turnover or DNA clearance. See related article by Mattox et al., p. 2166 (1).
©2023 American Association for Cancer Research.
Comment on
-
The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer.Cancer Discov. 2023 Oct 5;13(10):2166-2179. doi: 10.1158/2159-8290.CD-21-1252. Cancer Discov. 2023. PMID: 37565753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical